Senior Software Engineer, Pattern Bioscience

C++

Salary not provided

+ Equity

Docker

Python

Linux

C++

Senior and Expert level

Austin

Combatting antibiotic resistance

Open for applications

Combatting antibiotic resistance

21-100 employees

HealthcareB2BArtificial IntelligenceMachine Learning

Open for applications

Salary not provided

+ Equity

Docker

Python

Linux

C++

Senior and Expert level

Austin

21-100 employees

HealthcareB2BArtificial IntelligenceMachine Learning

Company mission

To advance single-cell microbiology to make targeted antimicrobial treatment informatio available days sooner.

Job

Company

Role

Who you are

Are an expert in C++ and fluent enough in Python to work across the stack
Are at home in Linux and comfortable with Docker
Have experience exposing C++ APIs to other languages
Have dealt with hardware interfaces, timing constraints, or real-time data pipelines
Have worked with distributed systems and large, complex datasets
Have inherited a non-trivial codebase and made it better
5+ years of industry C++ experience
Strong fundamentals in computer science and multi-threaded development
Startup experience is a plus (small team, high individual ownership, fast iteration)

What the job involves

We're looking for a Senior Software Engineer to own and advance that software
The codebase has history; part of the job is understanding it well enough to extend it without breaking things that matter. You'll work across a multidisciplinary team; firmware engineers, data scientists, and biologists, collaborating at the intersection of software and physical systems

Our take

Pattern Bioscience aims to make a significant impact in the battle against antibiotic-resistant infections, which have long been recognized as detrimental to our health and a major financial burden on the healthcare system.

It uses single-cell technology, eliminating the need for time-consuming bacterial cultures. This approach provides healthcare professionals with rapid and accurate information, enabling them to promptly prescribe the most effective antibiotics for their patients.

With investments from multiple organizations, Pattern Bioscience has been able to successfully develop its infectious disease diagnostic platform. While its initial focus was on pneumonia testing, the company achieved a significant milestone in 2021 when the FDA granted it breakthrough status. Currently, it is expanding its platform capabilities to enable a range of infectious disease tests in order to enhance its ability to address diverse medical challenges.

Freddie

Company Specialist at Welcome to the Jungle

Company

Funding (last 2 of 6 rounds)

Nov 2025

$43m

SERIES D

Apr 2023

$28.7m

SERIES C

Total funding: $92.1m

Company HQ

Congress Avenue Historic District, Austin, TX

Leadership

Nicolas Arab

(Co-Founder & CTO)

Previously worked at Luminex in various roles, including Electrical Engineering Manager and Senior Director of Advanced Technology.

Ross Johnson

(Co-Founder & Chief Engineer)

Graduated from the University of Texas with an Masters in Mechanical Engineering. Previously worked at Luminex as a Mechanical Engineer.

Carey-Ann Burnham

(CEO)

Initially joined Pattern Bioscience as CCO in 2022, becoming CEO in 2025. She has also been at the American Society for Microbiology since 2014, currently serving as an Editor in Chief for ASM Case Reports. Alongside this, she has been at Washington University School of Medicine in St. Louis since 2007, currently serving as a Professor of Pathology & Immunology, Molecular Microbiology, Pediatrics, and Medicine.

Salary benchmarks

We don't have enough data yet to provide salary benchmarks for this role.

Submit your salary to help other candidates with crowdsourced salary estimates.

Share this job